A large percentage of patients starting a medication take expensive brand-name products instead of biosimilars, even as health plans and PBMs work on converting existing brand-name prescriptions to ...
Andrea Iannucci, PharmD, BCOP, assistant chief pharmacist at UC Davis Health, spoke with The American Journal of Managed Care ® (AJMC ®) about the accessibility of new formulary drugs in oncology and ...
Paxton also led the creation of Rhazdrugs, the first comprehensive software dedicated to hazardous drug handling safety and USP <800> compliance. This solution was developed throu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback